Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011 Read more about Stereotaxis to Report Third Quarter 2011 Financial Results and Conduct Conference Call on November 7, 2011
Stereotaxis Appoints New Chief Financial Officer Read more about Stereotaxis Appoints New Chief Financial Officer
Stereotaxis to Present at the JMP Securities Healthcare Conference on September 28, 2011 Read more about Stereotaxis to Present at the JMP Securities Healthcare Conference on September 28, 2011
Stereotaxis' STOP-VT Prospective Multicenter Study Results Featured at Europe's Largest Medical Meeting, European Society of Cardiology Read more about Stereotaxis' STOP-VT Prospective Multicenter Study Results Featured at Europe's Largest Medical Meeting, European Society of Cardiology
Stereotaxis' Board of Directors Reaffirms Commercialization Plans for Epoch(TM) and Odyssey(TM) Product Platforms Read more about Stereotaxis' Board of Directors Reaffirms Commercialization Plans for Epoch(TM) and Odyssey(TM) Product Platforms
Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011 Read more about Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011
Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011 Read more about Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch(TM) and Odyssey(TM) Read more about Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch(TM) and Odyssey(TM)
Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011 Read more about Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
Stereotaxis and Biosense Webster Announce New Strategic Collaboration Read more about Stereotaxis and Biosense Webster Announce New Strategic Collaboration